| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| North America (Primary) | PRIMARYNOAM | Univ | 7,853 | 84,758,484 | 0.66% | 2.72% | 4.54% | 8.55% | 10.77% | 25.39% |
| Healthcare | HEALTHCARE | Sector | 1,208 | 6,888,039 | -0.62% | 1.44% | 2.99% | -5.73% | -2.65% | 14.75% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 605 | 3,847,669 | -0.47% | 2.55% | 7.18% | -3.19% | 6.13% | 36.04% |
| Non-System-Specific Biopharmaceuticals | BIOPHARMANONSYS | Industry | 213 | 788,483 | -0.88% | 3.36% | 3.10% | -4.11% | 16.32% | 45.06% |
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Infectious Disease Biopharmaceuticals | INFECTIOUS | SubInd | 45 | 225,690 | 0.20% | 2.54% | -0.26% | -12.40% | 1.17% | 28.39% |
| Non-System-Specific Biopharmaceuticals | BIOPHARMANONSYS | Industry | 213 | 788,483 | -0.88% | 3.36% | 3.10% | -4.11% | 16.32% | 45.06% |
| Oncology Biopharmaceuticals | ONCOLOGY | SubInd | 168 | 562,793 | -1.31% | 3.70% | 4.52% | -0.33% | 23.76% | 53.06% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,074 | 106,963,754 | 0.66% | 1.62% | 5.13% | 8.58% | 14.54% | 31.10% |
* Colors indicate performance relative to the benchmark.